AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Q3 2006 Takeda Chemical Industries Earnings Conference Call - Final.

Fair Disclosure Wire

| January 31, 2006 | COPYRIGHT 2006 CQ Transcriptions. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Original Source: FD (FAIR DISCLOSURE) WIRE

OPERATOR: Thank you for waiting. We will now begin teleconference. Please note that this telephone conference contains certain forward-looking statements and other projected results, which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations implied by these projections.

Such factors include economic and market conditions, political events and investor sentiments, liquidity of secondary markets, level and volatility of interest rates, currency exchange rates, security valuations, competitive conditions and size, number and timing of transactions.

During the presentation from the Company, all the telephone lines are placed for listening mode only, and a questions-and-answer session will be held after the presentation. This conference call is being broadcasted through Internet online, but only for listening mode.

Now we start the conference with a presentation.

HIROFUMI INOUE, IR, TAKEDA PHARMACEUTICAL COMPANY LIMITED: (technical difficulty) Conference call of third-quarter financial results for fiscal year ending March 2006 of Takeda Pharmaceutical Company Limited. My name is Hirofumi Inoue, Senior Manager, Public Relations, Investor Relations of Corporate Communications Department of Takeda.

Please let me introduce today's participants from Takeda -- Mr. Hiroshi Takahara, General Manager of Finance and the Accounting Department; Mr. Kazuaki Ikeya, General Manager of Strategic Product Planning Department; Mr. Yasuhiko Yamanaka, General Manager of Corporate Strategy and Planning Department.

Related articles from newspapers, magazines, journals, and more
Japan's Takeda Pharmaceutical H1 net profit 159.14 bln yen vs 181.27 bln yen.
News wire article from: Europe Intelligence Wire November 6, 2006 700+ words
...TOKYO (XFN-ASIA) - Takeda Pharmaceutical Co's results for the fiscal...September: Revenue - 642.43 bln yen vs 599.84 bln Opg profit - 236.22 bln yen vs 215.25 bln Current profit - 299.04 bln yen vs 259.43 bln Special punitive...
Takeda Pharmaceutical fails to declare 122.3 bil. yen in income.
Newspaper article from: Kyodo News International (Tokyo, Japan) June 28, 2006 700+ words
Jun. 28--OSAKA -- Takeda Pharmaceutical Co. said Wednesday it failed to declare 122.3 billion yen in taxable income over six years to March...Authorities imposed back taxes worth 57 billion yen under a transfer taxation system but Takeda...
Takeda Pharmaceutical objects order to pay 57 bil. yen in back taxes.
Newspaper article from: Kyodo News International (Tokyo, Japan) August 25, 2006 700+ words
Aug. 25--OSAKA -- Takeda Pharmaceutical Co. said Friday it filed an objection...Bureau's order to pay 57 billion yen in back taxes in connection with its...failed to declare 122.3 billion yen in taxable income in six years to...
Takeda: pharmaceutical sales up 7.0% to Yen 935.3 bn. [1 table].
News wire article from: Asia Africa Intelligence Wire May 31, 2004 700+ words
...Industries increased by 3.9% in year ended Mar 2004 to Yen 1086.4 bn. There was a 19.6% rise in operating profits to Yen 371.6 bn and an increase in ordinary profits of 10.1% to Yen 466.1 bn. Net profits were 5.0% higher at Yen 935...
Takeda Pharmaceutical, Hitachi Jointly Establish New Information System Company...
Magazine article from: JCNN News Summaries February 21, 2006 700+ words
...JCN) - Takeda Pharmaceutical and Hitachi...225 million yen ($1.9 mil...services to Takeda Pharmaceutical. Hitachi retains...company while Takeda Pharmaceutical holds the remaining...approximately 4 billion yen ($33.8...
Q1 2007 Takeda Pharmaceutical Company Limited Earnings Conference Call - Final.
News wire article from: The America's Intelligence Wire July 31, 2006 700+ words
...COMMUNICATIONS, TAKEDA PHARMACEUTICAL CO. LTD: Thank...March 2007 of the Takeda Pharmaceutical Company Ltd. I...STATSI MATSUNA, TAKEDA PHARMACEUTICAL CO. LTD: My name...first quarter, yen was weaker against...
Takeda Pharmaceutical to up medical representatives to 1700 within a year: May...
News wire article from: Asia Africa Intelligence Wire May 26, 2005 700+ words
...are to be employed by Takeda Pharmaceutical in year ending Mar 2005...outside of the company. Takeda Pharmaceutical is preparing to counteract...six leading drugs of Takeda Pharmaceutical accounted for 70% of its Yen 451.9 bn sales of...
Q3 2007 Takeda Pharmaceutical Company Limited Earnings Conference Call - Part 1.
News wire article from: The America's Intelligence Wire January 3, 2007 700+ words
...COMMUNICATIONS DEPARTMENT, TAKEDA PHARMACEUTICAL COMPANY LIMITED...ending March 2007 of Takeda Pharmaceutical Company Limited...ACCOUNTING DEPARTMENT, TAKEDA PHARMACEUTICAL COMPANY LIMITED...points. But the yen against the U...
Q3 2007 Takeda Pharmaceutical Company Limited Earnings Conference Call - Final.
News wire article from: Fair Disclosure Wire January 31, 2007 700+ words
...COMMUNICATIONS DEPARTMENT, TAKEDA PHARMACEUTICAL COMPANY LIMITED...ending March 2007 of Takeda Pharmaceutical Company Limited...ACCOUNTING DEPARTMENT, TAKEDA PHARMACEUTICAL COMPANY LIMITED...points. But the yen against the U...
Takeda Pharmaceutical Raises Earnings Forecast for FY 2008.
Newspaper article from: Jiji July 31, 2008 700+ words
...Tokyo, July 31 (Jiji Press)--Takeda Pharmaceutical Co. on Thursday revised upward its...operating profit forecast to 280 billion yen from 240 billion yen, recurring profit forecast to 300 billion yen from 260 billion yen, and net profit...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA